Next Article in Journal
Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
Next Article in Special Issue
Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation
Previous Article in Journal
Systematic Booster after Rabies Pre-Exposure Prophylaxis to Alleviate Rabies Antibody Monitoring in Individuals at Risk of Occupational Exposure
Previous Article in Special Issue
Silicone Oil-Based Nanoadjuvants as Candidates for a New Formulation of Intranasal Vaccines
 
 
Article

Article Versions Notes

Vaccines 2021, 9(4), 310; https://doi.org/10.3390/vaccines9040310
Action Date Notes Link
article xml file uploaded 25 March 2021 06:46 CET Original file -
article xml uploaded. 25 March 2021 06:46 CET Update https://www.mdpi.com/2076-393X/9/4/310/xml
article pdf uploaded. 25 March 2021 06:46 CET Version of Record https://www.mdpi.com/2076-393X/9/4/310/pdf
article html file updated 25 March 2021 06:47 CET Original file -
article html file updated 3 August 2021 02:11 CEST Update -
article html file updated 25 July 2022 09:09 CEST Update https://www.mdpi.com/2076-393X/9/4/310/html
Back to TopTop